News

PromarkerD Hits Latin America

Proteomics International is pleased to announce that the company’s PromarkerD test for kidney disease is set to improve the lives of diabetics in Latin America with a new million dollar deal to commercialise the test in the region.

Media release

Subscribe
  • This field is for validation purposes and should be left unchanged.